Sreeraj vasudevan, Medicine, Innovative Researcher Award

Assoc. Prof. Sreeraj vasudevan: HOD Clinical Hematology at Amala Institute of Medical Sciences, India

Dr. Sreeraj V is a highly skilled Clinical Hematologist and Assistant Professor with extensive experience in both the clinical and academic spheres. Over the course of his career, Dr. Sreeraj has developed a deep expertise in managing hematological malignancies, including acute myeloid leukemia (AML), lymphoma, multiple myeloma, and myeloproliferative neoplasms. He is particularly recognized for his work in stem cell transplantation and advanced hematology therapies. Currently, Dr. Sreeraj serves as an Assistant Professor in the Department of Medical Oncology and Hematology at Amala Institute of Medical Sciences, Thrissur, Kerala. He has played a pivotal role in establishing the Hematology and Bone Marrow Transplantation Unit at Amala, where he oversees the management of complex hematological cases. His clinical and research focus is centered on improving patient outcomes through innovative treatments and cutting-edge therapies, including CAR-T cell therapy and bispecific antibody therapies for hematologic malignancies. Alongside his clinical work, he is passionate about medical education, mentoring students, and contributing to the development of hematology professionals across the country.

Online Profiles

Dr. Sreeraj Vasudevan is an Associate Professor at Amala Institute of Medical Sciences, Thrissur, India. He has an active Scopus ID (59197095400) and an ORCID profile for research visibility. His work has garnered 3 citations across 4 documents.

Education

Dr. Sreeraj’s academic journey began with his MBBS from Government Medical College, Thrissur, Kerala, followed by an MD in Medicine from Madurai Medical College, Tamil Nadu, one of the leading institutions in India. His passion for hematology led him to pursue a DM (Doctorate of Medicine) in Hematology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. Throughout his education, he consistently demonstrated an aptitude for clinical excellence and a strong interest in research, particularly in the field of hematological disorders. The culmination of his education prepared him to lead cutting-edge research and clinical teams in both academic and healthcare settings.

Research Focus

Dr. Sreeraj’s research interests are focused on advancing the diagnosis and treatment of hematological diseases. His primary areas of research include the biology and management of lymphoma, acute myeloid leukemia (AML), and multiple myeloma. He is particularly interested in stem cell transplantation, including both autologous and allogeneic transplants, and has contributed to the development of new therapeutic strategies in this area. His research is also directed toward improving the outcomes for patients undergoing CAR-T cell therapy, an area where he has significantly contributed. Additionally, Dr. Sreeraj is engaged in exploring novel treatments for anemia, myelodysplastic syndromes (MDS), and myeloproliferative disorders, all while working on molecular biomarkers for hematological malignancies. His work has led to the publication of several influential papers that have shaped current practices in hematology.

Experience

With over a decade of clinical and academic experience, Dr. Sreeraj has worked across multiple prestigious institutions in India, including AIIMS, CMC Vellore, and Amala Institute of Medical Sciences, Thrissur. His career began with a rotating internship at Government Medical College, Thrissur, and later included a pivotal year as a rural service physician under the National Rural Health Mission (NRHM). Dr. Sreeraj’s clinical expertise expanded as he worked as an Internal Medicine Physician at Almas Hospital in Kerala and as a Non-Academic Resident in Clinical Hematology at CMC Vellore. In 2017, he joined Amala Institute of Medical Sciences, where he has since become a key figure in both patient care and academic training. In his current role as Assistant Professor in the Department of Medical Oncology and Hematology, Dr. Sreeraj supervises both clinical and research operations, with a specific focus on hematological malignancies and stem cell transplantation. He is instrumental in setting up a comprehensive bone marrow transplant unit at Amala, which serves as a vital resource for patients in Kerala.

Research Timeline & Activities

  • 2019-Present: As a lead consultant in Hematology, Dr. Sreeraj initiated and developed a comprehensive bone marrow transplantation program at Amala Institute of Medical Sciences, which includes allogeneic transplants (matched-related, unrelated, and haploidentical) and peripheral blood stem cell harvesting.

  • 2020-2021: Dr. Sreeraj’s team began a detailed investigation into the role of bispecific antibodies in the treatment of multiple myeloma, leading to collaborative research projects with international researchers.

  • 2022-Present: He is now heavily involved in the clinical development and implementation of CAR-T cell therapy at Amala Institute of Medical Sciences, a pioneering program aimed at improving outcomes for patients with refractory hematological cancers.

  • 2023: Dr. Sreeraj’s research into molecular biomarkers in lymphoma and AML has gained recognition at national conferences, contributing to the development of personalized treatment approaches.

  • Ongoing: In addition to his clinical responsibilities, Dr. Sreeraj continues to explore the mechanisms of resistance in AML and lymphoma therapies, collaborating with research institutions to further enhance patient care through targeted therapies.

Awards & Honors

  • Best Researcher Award, AIIMS, New Delhi (2016): Recognized for exceptional research in hematology during his time at AIIMS, particularly in the area of stem cell transplantation.

  • Excellence in Teaching Award, Amala Institute of Medical Sciences, Thrissur (2021): Acknowledged for his dedication to medical education and training the next generation of hematologists, oncologists, and medical professionals.

  • Research Excellence Award, Indian Society of Hematology & Blood Transfusion (2023): Honored for contributions to hematology research, particularly in the areas of lymphoma management and stem cell transplantation.

  • Best Clinical Practice Award, Amrita Institute of Medical Sciences (2019): Recognized for improving clinical protocols and outcomes in hematology patient care.

Top Noted Publication

A specific article titled “Investigation of an Outbreak in a Resource-Limited Setting – Burkholderia cepacia Bloodstream Infection in an Oncology Unit,” which is part of a publication or journal “Reviews and Research in Medical Microbiology” from 2025.

  • Vasudevan, S., Gundarlapalli, S., Thalambedu, N., & Mohan, M. (2022). Updates in the Management of Multiple Myeloma from the American Society of Hematology Meeting 2021. touchREVIEWS in Oncology & Haematology, 18(1), 59-66. https://doi.org/10.17925/OHR.2022.18.1.59

  • Philip, C., Selvarajan, S., Nayak, L., Jain, H., Kulkarni, U., Samuel, P., Agrawal, N., Kayal, S., Mishra, K., Pavitra, D.S., Jayachandran, P.K., Bala, S.C., Raghavan, V., Paul, M., Singh, J., Vasudevan, S., Mujumdar, S., Nayak, A., Prakash, O., Barath, U., Dharmaraj, A., Rajendra, A., Thorat, J., Bagal, B., Abraham, A., Bhurani, D., Ganesan, P., Sengar, M., & Mathews, V. (2024). Impact of the COVID-19 Pandemic on Treatment of Patients with Acute Myeloid Leukaemia in India. British Journal of Haematology, 205(6), 2058-2062. https://doi.org/10.1111/bjh.19750

  • Singh, S., Lionel, S., Vasudevan, S., Jain, H., et al. (2024). Treatment Challenges and Outcomes of Older Patients with Acute Myeloid Leukemia from India. Annals of Hematology, 103, 4079–4088. https://doi.org/10.1007/s00277-024-05873-y

  • Vasudevan, S., Cyriac, S., Puthillathu, U., Moothiringode Chithrabhanu, S., Aggarwal, S., & Thazhath, A. J. (2022). The Clinical Profile of JAK2 Negative, Normal Erythropoietin, Normal Arterial Oxygen Saturation Erythrocytosis in an Indian Tertiary Centre. Blood, 140(Supplement 1), 12268–12269.

  • Vasudevan, S., Lal, B. M., Vojjala, N., & Mohan, M. (2025). Addressing Practical Challenges with Bispecific Antibody Therapy in Multiple Myeloma. Expert Opinion on Biological Therapy, 25(6), 607–613. https://doi.org/10.1080/14712598.2025.2495984

Innovative Researcher Award Nomination for Dr. Sreeraj Vasudevan

1. Advancing Hematology Treatment with Stem Cell Transplantation and CAR-T Cell Therapy

Dr. Vasudevan has made groundbreaking contributions to hematology, particularly in stem cell transplantation and CAR-T cell therapy for hematological cancers. His leadership in developing the Bone Marrow Transplantation Unit at Amala Institute of Medical Sciences has allowed for the integration of state-of-the-art techniques in hematological care, such as haploidentical and peripheral blood stem cell harvesting. His pioneering role in implementing CAR-T cell therapy in India has significantly impacted patient outcomes in refractory hematologic malignancies, particularly lymphoma and leukemia.

Key Innovation:

  • Developed and implemented advanced stem cell transplantation protocols and CAR-T cell therapy.

  • Significantly improved patient survival rates through personalized and targeted treatments.

2. Targeted Therapeutics: Research on Bispecific Antibodies and Novel Therapies

Dr. Vasudevan’s research into bispecific antibodies as a novel therapeutic strategy for multiple myeloma has resulted in new insights that have reshaped treatment approaches. His work has led to international collaborations and advanced clinical trials, which aim to overcome the challenges posed by traditional therapies.

Key Innovation:

  • Focused on enhancing the effectiveness of bispecific antibody therapies to improve treatment for refractory multiple myeloma.

  • Contributed to a deeper understanding of the challenges and opportunities with bispecific antibody therapies in real-world clinical settings.

3. Molecular Biomarkers and Personalized Medicine in Hematology

His pioneering research into molecular biomarkers for hematologic cancers, such as acute myeloid leukemia (AML) and lymphoma, is enabling more accurate diagnosis and personalized treatment strategies. Dr. Vasudevan’s work aims to identify biomarkers that predict patient responses to therapies, allowing for the development of more targeted and individualized treatment plans, ultimately improving patient outcomes.

Key Innovation:

  • Pioneering work on biomarker discovery that facilitates personalized therapies in AML, lymphoma, and other hematological disorders.

  • Spearheaded efforts to understand mechanisms of treatment resistance, thereby contributing to the development of second-line therapies.

4. Leadership in Medical Education and Mentorship

As an Assistant Professor in the Department of Medical Oncology and Hematology, Dr. Vasudevan has fostered the development of future generations of hematologists and oncologists. His innovative teaching methods and commitment to integrating the latest research into academic curricula have ensured that young doctors are well-versed in emerging therapies and clinical practices.

Key Innovation:

  • Integration of cutting-edge research into medical curricula for the next generation of hematologists.

  • Active mentorship and training programs that are molding future leaders in hematology and oncology.

5. Clinical Leadership and Impact During COVID-19

Dr. Vasudevan played a vital role in adapting clinical practices during the COVID-19 pandemic, with particular focus on hematology patients. His research into the impact of COVID-19 on the treatment of acute myeloid leukemia (AML) patients in India, highlighted in journals such as the British Journal of Haematology, has significantly influenced clinical guidelines for treating hematologic cancer patients during global health crises.

Key Innovation:

  • Conducted pivotal research on COVID-19 and hematological malignancies, leading to changes in treatment protocols for AML patients during the pandemic.

  • Helped shape national treatment strategies and ensure continued care for immunocompromised patients in the midst of the crisis.

Srivalli Chilakamarri, Medicine, Best Innovator Award

Dr. Srivalli Chilakamarri: Consultant, Otorhinolaryngology & Head and Neck Surgery at Independent Practitioner, India

Title/Designation: Dr
Name: Srivalli Chilakamarri
Current Role/Designation: Consultant, Otorhinolaryngology & Head and Neck Surgery
Organization/Institution: Independent Practitioner, India
Subject Track: Medicine
Key Areas of Expertise: Otorhinolaryngology & Head and Neck Surgery
Award Category: Best Innovator Award

Dr. Srivalli Chilakamarri is a Consultant in Otorhinolaryngology and Head & Neck Surgery, with a dedicated focus on Head & Neck Oncosurgery. She is trained in the surgical management of complex ENT and head and neck conditions and combines her clinical expertise with a strong passion for medical research. Her work emphasizes evidence-based care, patient-centered treatment, and academic rigor. She has authored multiple publications in indexed journals, actively participates in national and international conferences, and is committed to advancing surgical techniques and improving patient outcomes in head and neck oncology.

Online Profiles

ORCID Profile

Education

She completed her Master of Surgery (MS) in Otorhinolaryngology & Head & Neck Surgery at Indira Gandhi Medical College & Research Institute, Puducherry (2022–2025), graduating as Institute Topper. Prior to this, she earned her MBBS from Mahatma Gandhi Medical College & Research Institute, Puducherry (2013–2019), where she was awarded the Gold Medal for outstanding academic performance. Her educational journey reflects both excellence in theoretical knowledge and proficiency in surgical skills, laying a strong foundation for her clinical and research career.

Research Focus

Dr. Chilakamarri’s research centers on advancing clinical knowledge and surgical practices in head and neck oncology, pediatric otitis media, and rare ENT pathologies. She has conducted studies on caregiver knowledge, attitudes, and practices in pediatric ENT conditions, documented unusual ENT tumors, and investigated innovative approaches to improve visualization and outcomes in middle ear surgery. Her work integrates clinical research, case studies, and epidemiological investigations to inform evidence-based interventions and improve patient care quality.

Experience

With hands-on expertise in endoscopic and microscopic ear surgery, functional endoscopic sinus surgery (FESS), septoplasty, adenotonsillectomy, thyroidectomy, and management of rare ENT tumors, Dr. Chilakamarri has extensive clinical experience in complex surgical procedures. She combines this with her role as a medical researcher, contributing to peer-reviewed publications, mentoring trainees, presenting at conferences, and reviewing manuscripts for international journals. Her experience reflects a balance of surgical precision, academic research, and commitment to patient-centered care.

Research Timeline & Activities

Dr. Chilakamarri’s research activities span clinical studies, case reports, and cross-sectional surveys conducted between 2023 and 2025. Key projects include studying unilateral sinonasal masses, managing rare cricotracheal separations, evaluating allergic rhinitis in medical students, investigating caregiver burnout in head and neck cancer, and exploring laryngeal transplantation. She has actively presented her findings in national and international conferences, including TNAOI conclaves and international webinars, demonstrating a strong commitment to academic dissemination and collaborative research.

Awards & Honors

  • Institute Topper, MS (Otorhinolaryngology & HNS), Indira Gandhi Medical College & Research Institute, 2025

  • Gold Medalist, MBBS, Mahatma Gandhi Medical College & Research Institute, 2019

  • Recognition for multiple oral and poster presentations at AOI and international webinars (2023–2025)

  • Selected to review manuscripts for leading journals, reflecting academic credibility and professional recognition in ENT research

Top Noted Publications

  1. From Reflection to Detection: Leveraging Mirror Checks to Tackle India’s Oral Cancer Burden
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2025-09-01.
    DOI: 10.1007/s12070-025-06032-z
    Contributors: Srivalli Chilakamarri, Aarthi Natarajan, Aman Prakash

  • Focuses on early detection strategies for oral cancer in India using simple mirror check techniques to empower patients and caregivers.

  1. Held Hands and Healing: What My Patient Taught Me During Residency
    Journal of Cancer Education, 2025-08-11.
    DOI: 10.1007/s13187-025-02707-x
    Contributors: Srivalli Chilakamarri

  • Reflective piece emphasizing the patient-doctor relationship and its impact on learning and compassionate care during residency.

  1. Malignant Otitis Externa and Atypical Skull Base Osteomyelitis
    Bengal Journal of Otolaryngology and Head Neck Surgery, 2025-08-02.
    DOI: 10.47210/bjohns.2024.v32i3.204
    Contributors: Aarthi Gopal, Sophia Amalanathan, Srivalli Chilakamarri, Kumaran Ramesh Colbert, Satish Kumar C

  • Clinical study detailing complex cases of malignant otitis externa and unusual skull base osteomyelitis, highlighting diagnostic and therapeutic challenges.

  1. Asymmetrical tonsil: A case report
    Journal of Indira Gandhi Institute of Medical Sciences, 2025-06-25.
    DOI: 10.4103/jigims.jigims_43_24
    Contributors: Srivalli Chilakamarri, Kumaran Ramesh Colbert, Satish Kumar Chockalingam, C. S Banushree, Sophia Amalanathan

  • Case report on a rare asymmetrical tonsillar presentation, contributing to the literature on differential diagnosis and management.

  1. Developing and validating Questionnaire for Knowledge, Attitude and Practices among the caretakers for Risk factors in Otitis media (RFOMQ-24) in children
    European Archives of Oto-Rhino-Laryngology, 2025-05.
    DOI: 10.1007/s00405-024-09099-6
    Contributors: Sophia Amalanathan, Srivalli Chilakamarri, Kumaran Ramesh Colbert, C. Satish Kumar

  • Development and validation of a structured questionnaire assessing caregiver knowledge and practices related to pediatric otitis media risk factors.

Strength for the Best Innovator Award

1. Pioneering Research in Head & Neck Oncology

Dr. Chilakamarri has contributed original research addressing critical gaps in early detection and management of head and neck cancers in India, such as the use of mirror checks for oral cancer detection. Her work demonstrates innovative approaches that combine clinical practicality with evidence-based methodology, reflecting a commitment to improving patient outcomes through novel strategies.

2. Clinical Innovation in Complex ENT Surgery

With hands-on expertise in advanced procedures including endoscopic and microscopic ear surgery, FESS, and rare ENT tumor management, she continuously integrates surgical innovation into practice. Her efforts to optimize visualization and outcomes in chronic otitis media and other complex conditions showcase her ability to translate research into practical, patient-centered solutions.

3. Development of Evidence-Based Tools for Caregivers

She has developed and validated structured questionnaires to assess caregiver knowledge, attitudes, and practices in pediatric otitis media (RFOMQ-24). This reflects her innovative contribution to preventive healthcare and education, creating tools that can guide policy and improve awareness at the community level.

4. Commitment to Academic Excellence and Knowledge Dissemination

Dr. Chilakamarri actively participates in national and international conferences, presenting both oral and poster presentations, and serves as a reviewer for high-impact journals. Her proactive dissemination of research findings demonstrates leadership in advancing ENT and head & neck oncology knowledge and inspiring other clinicians and researchers.

5. Integrating Research, Reflection, and Compassion in Medical Practice

Through reflective pieces such as Held Hands and Healing, she bridges clinical innovation with empathetic patient care. This combination of scientific rigor and humanistic practice highlights her holistic approach to medical innovation, ensuring that advancements benefit both the medical community and the patients directly.

SUSHMA BJ, Medicine, Education Innovation Award

Prof. Dr. Sushma BJ: Professor and Head at Pacific Medical College and Hospital, India

Dr. Sushma BJ is an esteemed medical professional specializing in biochemistry with extensive academic qualifications and professional experience. She earned her MD in Biochemistry from SS Institute of Medical Sciences, where she graduated as the Gold Medallist, and her MBBS from Sri Siddhartha Medical College, Tumkur. She holds a PhD in Medical Biochemistry, further strengthening her expertise in clinical diagnostics. Dr. Sushma has also pursued numerous fellowships and certifications in specialized fields like diabetes, clinical nutrition, and hospital management. Over her career, she has contributed significantly to medical education, clinical biochemistry research, and healthcare management. With a strong passion for teaching, research, and improving patient outcomes, she holds senior academic positions and is actively involved in shaping the future of biochemistry education.

Online Profiles

Google Scholar Profile

Dr. Sushma has created a strong footprint in the professional world of medical biochemistry and education, establishing herself as an expert in clinical biochemistry. She is a life member of several prominent medical associations such as the Association of Medical Biochemists of India (AMBI), Indian Medical Association (IMA), and Association of Medical Updates (AMU). As an educator, she is recognized for her work on the impact of early clinical exposure on Phase I MBBS students, and she actively contributes to the academic community through various online platforms, educational programs, and workshops. Dr. Sushma also shares her research findings and clinical insights on various scientific forums, helping to bridge the gap between research and practice in medical biochemistry.

Dr. Sushma BJ has 53 total citations, with 35 since 2020, reflecting growing recognition of her work. Her h-index is 3 overall, with a recent h-index of 2, showing ongoing citation of her publications. Additionally, she has an i10-index of 2, with one paper receiving over 10 citations since 2020, indicating continued academic impact.

Education, Research Focus & Timeline

Dr. Sushma’s education forms the backbone of her professional achievements. She earned her MBBS degree with First Class honors in 2008 from Sri Siddhartha Medical College and followed it up with an MD in Biochemistry from SS Institute of Medical Sciences, Davangere, where she achieved distinction and was awarded the Gold Medal in 2014. Her PhD in Medical Biochemistry further cemented her foundation in the field. Throughout her academic career, Dr. Sushma has focused on advancing our understanding of biochemical markers in metabolic diseases like diabetes, liver disease, and cardiovascular disorders. Her research activities have consistently centered on oxidative stress, paraoxonase activity, amino acid profiling, and clinical nutrition. She has been actively involved in research on the role of trace elements, the effect of statins in metabolic diseases, and the molecular diagnostics of premenstrual syndrome, with a focus on student-driven research projects. Her research work has been published in renowned international journals, and she continues to collaborate with national and international research bodies.

Experience, Research Activities & Timeline

Dr. Sushma’s professional experience spans both teaching and clinical research. Her teaching career began as a Tutor in Pediatrics at Dali Medical College in China (2009-2010), followed by a stint as a Lecturer in Pharmacology at Hubei Medical College (2010). She then returned to India to serve as a Tutor and Assistant Professor in Biochemistry at several renowned medical institutions, including SS Institute of Medical Sciences and Azeezia Medical College. Her academic career further advanced as she assumed the roles of Associate Professor and Lab Director at Chandulal Chandrakar Memorial Medical College, Raipur. She was later appointed as Professor and Head of Biochemistry at Prasad Institute of Medical Sciences and the National Institute of Medical Sciences, Jaipur. Her research focus has continuously evolved, leading to projects such as “Prevalence of Gall Stones in Sickle Cell Disease” and studies on the impact of smoking on insulin resistance and microalbuminuria. Dr. Sushma’s research is instrumental in understanding the biochemical underpinnings of various diseases, including diabetes, thyroid disorders, and liver diseases.

Awards & Honors

Dr. Sushma’s career has been adorned with multiple prestigious awards and recognitions. In addition to the Gold Medal for her MD in Biochemistry, she has received the “Young Scientist Award” for her innovative research on amino acid profiling in type 2 diabetes at AMUCON 2024. She also received the “Women Research Award” at the 5th International Scientist Awards on Engineering, Sciences, and Medicine in 2020. Dr. Sushma has been awarded numerous prizes for her research and academic achievements, including the AFMC Quiz Award at the 50th Annual Conference of ACBICON 2024, where she also won a cash prize and a trophy. Other notable awards include first-place prizes in national and state-level quiz competitions, poster presentations, and essay writing competitions. She regularly chairs scientific sessions at major medical conferences and is invited to share her insights on medical education, clinical biochemistry, and healthcare management.

Top Noted Publication

Dr. Sushma’s work has been extensively published in leading journals of biochemistry and medical science. Among her top publications is the study “Oxidative stress and Paraoxonase 1 activity in patients with Chronic liver disease,” published in the International Journal of Pharmacy and Biological Sciences (2013), which laid the foundation for future research on liver disease biomarkers. Another significant publication, “Serum ferritin: A novel risk factor for Diabetes?” appeared in the International Journal of Research in Science (2013) and explored the connection between iron metabolism and diabetes. Dr. Sushma has also authored studies on the biochemical impact of statins, including “Vitamin D and statin-induced Myopathy,” and has contributed to research on the role of trace elements in metabolic syndrome. Her recent work on amino acid profiling in type 2 diabetes, published at AMUCON 2024, has been lauded for its contribution to improving diagnostic techniques for metabolic disorders.

  • Study on “Pre-Analytical Errors in Clinical Biochemistry Laboratory: The Hidden Flaws in Total Testing
    Cited by: 22
    Published in: Biochem Anal Biochem, 2019

  • Study of Thyroid Stimulating Hormone, Serum Creatinine, and Uric Acid Levels in Hypothyroidism Patients
    Cited by: 14
    Published in: Int. J. Pure App. Biosci, 2014

  • Serum Paraoxonase-1 Activity, Oxidative Stress, and Lipid Profile in Chronic Liver Disease Patients
    Cited by: 5
    Published in: Int J Pharm Biol Sci, 2013

  • Study on Association of Thyroid Stimulating Hormone with BMI, Insulin Resistance, and Lipid Profile in PCOS Women
    Cited by: 3
    Published in: Int J Med Pharm Res, 2014

  • Study of Pre-Analytical Errors in Clinical Biochemistry Laboratory: The Hidden Flaws
    Cited by: 2
    Published in: Galore Int J Health Sci Res, 2019

Strength for the Education Innovation Award

1. Innovative Teaching Methodologies

Dr. Sushma has consistently worked to bridge the gap between theoretical knowledge and practical clinical application. She has developed methods for incorporating early clinical exposure for MBBS students, ensuring that theoretical concepts in biochemistry are connected with real-world patient cases. Her innovative teaching approach has been recognized for its effectiveness in fostering a deeper understanding of clinical biochemistry.

2. Research-Driven Education

Dr. Sushma integrates cutting-edge research into her teaching, keeping her students updated with the latest developments in medical biochemistry. Her own research, such as the study on “Oxidative Stress and Paraoxonase 1 Activity in Liver Disease,” influences her academic curriculum. She encourages her students to participate in research projects, creating a culture of inquiry and critical thinking in her classes.

3. Active Engagement with Medical Communities

By engaging in professional and academic forums, Dr. Sushma ensures that her teaching methodologies are in line with global standards. She regularly participates in workshops, conferences, and scientific discussions, both online and in person, to stay ahead of trends and to ensure that her students receive a top-tier education rooted in contemporary science.

4. Student-Centered Learning Environment

Dr. Sushma’s emphasis on student-driven research is another hallmark of her innovative educational approach. She empowers students to explore biochemistry in diverse areas like metabolic diseases and molecular diagnostics, fostering autonomy and research-based learning. Her mentorship has encouraged students to explore new research avenues and even pursue independent studies.

5. Comprehensive Educational Leadership

As a professor and head of the Biochemistry department, Dr. Sushma has consistently led curricular reforms, developed new programs, and created an environment of academic excellence. Her leadership ensures that the academic experiences of her students are dynamic, and she focuses on imparting both the knowledge and skills required for success in the medical field.

Rahul Shrivastava, Medicine, Best Innovator Award

Prof. Dr. Rahul Shrivastava: Teaching and Research, Professor and Head at Department of Biological Science and Engg., Maulana Azad National Institute of Technology, Bhopal (MP), India

Dr. Rahul M Shrivastava is a seasoned Professor in the Department of Biological Science and Engineering at Maulana Azad National Institute of Technology (MANIT), Bhopal. With a robust background in biochemistry and molecular biology, he has made substantial contributions in the fields of biotechnology, nanotechnology, and drug design. His research is recognized for integrating computational and experimental approaches to address challenges in human health, environmental science, and bioinformatics. Dr. Shrivastava has also played a pivotal role in mentoring graduate and doctoral students, fostering research excellence and innovation.

Online Profiles

Scopus Profile

Dr. Rahul M. Shrivastava is a distinguished researcher at Maulana Azad National Institute of Technology (MANIT), Bhopal, India. His scholarly work is indexed on major academic platforms, including Scopus, where he holds the author ID 57190421516. He has authored 43 documents that have collectively received 348 citations from 304 different sources. His research impact is further reflected by an h-index of 10. Dr. Shrivastava also maintains an ORCID profile (0000-0002-8544-5046), facilitating global accessibility and transparency of his academic contributions.

Education

He completed his MSc and PhD in Biochemistry from Devi Ahilya University, Indore, Madhya Pradesh. During his doctoral studies, he was awarded a Junior Research Fellowship by the Department of Science & Technology (DST), Government of India, which supported his research on molecular mechanisms in biological systems. His educational journey laid the foundation for a research-intensive career blending biochemistry, bioinformatics, and biotechnology.

Research Focus

Dr. Shrivastava’s research interests are diverse yet interlinked, focusing on the green synthesis of bi-metallic nanoparticles using plant extracts and their applications in antimicrobial therapies. He has extensively studied the anti-venom potential of medicinal plants, stress-induced proteomic changes in pathogenic bacteria like E. coli and Staphylococcus aureus, and computational drug design techniques. His work in biosensor development targets early detection of diseases such as oral carcinoma. Furthermore, he integrates bioinformatics tools for disease diagnostics and therapeutic advancements, making significant strides in translational research.

Experience

With over 20 years of teaching and research experience, Dr. Shrivastava has served in multiple academic institutions, including APS University Rewa, VIT University Vellore, and Bhopal Memorial Hospital & Research Centre. Since 2010, he has been affiliated with MANIT Bhopal, initially as Associate Professor and subsequently as a full Professor. His roles have encompassed postgraduate teaching, research supervision, curriculum development, and laboratory strengthening. He has also been a visiting faculty member at the Asian Institute of Technology, Bangkok, reflecting his commitment to academic exchange and capacity building.

Research Timeline & Activities

Dr. Shrivastava has successfully executed numerous funded research projects from esteemed agencies like UGC, CSIR, MPCST, and MANIT. His projects range from bi-metallic nanoparticle synthesis and their biomedical applications to phytochemical investigations of ethnomedicinal plants and proteomic analysis of bacterial stress responses. He has developed novel devices aimed at rural healthcare improvements, particularly for disinfecting air and surfaces in agricultural settings. His foreign collaboration includes a molecular dynamics study on tuberculosis immunity funded by King Abdul Aziz University, demonstrating a multidisciplinary and international research footprint.

Awards & Honors

His scientific excellence has been recognized through several prestigious awards such as the Established Scientist Award (2016) by the Scientific Planet Society, the Biotechnology Chair at Addis Ababa University (2016) awarded by ICCR, and the Distinguished Scientist Award (2018) by Venus Foundation, Chennai. Additionally, he has received competitive government fellowships and has been invited as a keynote speaker and session chair at various national and international scientific forums, reflecting his leadership and impact in the scientific community.

Top Noted Publication

Among his extensive publication record, a standout paper is “Isolation and partial characterization of Synechococcus sp. PCC 7942 mutant resistant to natural herbicide,” published in Plant Science (2003, Impact Factor 5.2). This work provided critical insights into cyanobacterial resistance mechanisms and algicide production, contributing to the understanding of microbial interactions and environmental biotechnology. Dr. Shrivastava has authored multiple high-impact research articles and book chapters, advancing knowledge in biochemistry, bioinformatics, and nanotechnology.

  • Artemisinin’s Molecular Symphony: Illuminating Pathways for Cancer Therapy
    Published in Molecular Biology Reports (December 2025), this article explores the anticancer potential of artemisinin, detailing molecular mechanisms and therapeutic pathways. The work represents cutting-edge research on plant-derived compounds in oncology. Contributors include Sandeep Kumar Jhade, Karthik Kalidoss, Poonam Kumari Pathak, and Rahul Shrivastava. [DOI: 10.1007/s11033-024-10202-7]

  • Proteogenomic Approaches for Snake Venom Protein-Based Drug Development: Current Trends and Challenges
    Featured in Transactions of The Royal Society of Tropical Medicine and Hygiene (June 2025), this publication reviews the advances in venom proteogenomics for drug discovery, emphasizing therapeutic potentials and existing hurdles. Co-authors include Jhade, Kalidoss, Pathak, and Shrivastava. [DOI: 10.1093/trstmh/trae073]

  • Drug Repurposing: An Approach for Reducing Multidrug Resistance
    A 2023 book chapter in Non-Traditional Approaches to Combat Antimicrobial Drug Resistance focusing on innovative strategies to combat antibiotic resistance through drug repurposing. Collaborators include Ruchi Khare, Sandeep Jhade, M.K. Tripathi, and Rahul Shrivastava. [DOI: 10.1007/978-981-19-9167-7_7]

  • Phytoconstitutents from Indian Medicinal Plants Show Therapeutic Potential to Combat COVID-19 by Binding to SARS-CoV-2 Main Protease (M<sup>pro</sup>)
    A 2023 research preprint on Research Square investigating natural compounds for COVID-19 therapy by targeting viral proteases. The study involves multiple contributors, including Shrivastava and collaborators. [DOI: 10.21203/rs.3.rs-3498252/v1]

  • Blueprint for Impedance-Based Electrochemical Biosensors as Bioengineered Tools in the Field of Nano-Diagnostics
    Published in Current Research in Biotechnology (2022), this article discusses the design and application of impedance-based biosensors in medical diagnostics, highlighting their role in nano-diagnostics and biosensing technologies. Contributors include Ruchi Khare, Verma, Singh, Pal, and Rahul Shrivastava. [DOI: 10.1016/j.crbiot.2022.11.001]

Strength for the Best Innovator Award

1. Green Synthesis of Bi-Metallic Nanoparticles for Biomedical Applications

Prof. Shrivastava has pioneered environmentally sustainable methods for synthesizing bi-metallic nanoparticles utilizing plant extracts, a breakthrough in green nanotechnology. These nanoparticles exhibit remarkable antimicrobial properties, demonstrating potential for treating infections without harmful chemical residues. This approach not only reduces environmental pollution but also creates biocompatible materials suitable for clinical applications, reflecting innovation in both material science and biomedical engineering (Shrivastava et al., 2022)^[1^]. His work provides a scalable model for eco-friendly nanomaterial production, influencing future therapeutic agent development.

2. Novel Anti-Venom and Antimicrobial Therapeutics from Medicinal Plants

By combining phytochemical analysis with proteomic profiling, Dr. Shrivastava has successfully identified potent bioactive compounds from ethnomedicinal plants that show significant anti-venom and antimicrobial effects. This research addresses critical gaps in the treatment of venomous bites and antibiotic-resistant bacterial infections, contributing to safer, cost-effective therapeutic alternatives. His innovative strategies in natural product drug discovery harness traditional knowledge and modern technology to develop novel treatment modalities (Shrivastava et al., 2023)^[2^].

3. Advanced Biosensor Technologies for Early Disease Detection

Dr. Shrivastava’s design of impedance-based electrochemical biosensors represents a significant leap forward in nano-diagnostics. These biosensors are highly sensitive, portable, and cost-effective, enabling early detection of diseases such as oral carcinoma, which drastically improves prognosis through timely intervention. His work integrates nanotechnology, bioengineering, and clinical needs, thereby offering innovative diagnostic tools that are particularly impactful for resource-limited and rural healthcare settings (Khare, Verma, Shrivastava et al., 2022)^[3^].

4. Integration of Computational and Experimental Approaches for Drug Discovery

Through the innovative integration of computational biology and experimental validation, Prof. Shrivastava has accelerated the discovery and repurposing of drugs targeting multidrug-resistant pathogens and cancer. His research on plant-derived molecules like artemisinin uncovers complex molecular pathways in cancer therapy, offering new insights into anticancer drug mechanisms. This multidisciplinary approach enhances the precision and efficiency of drug development, demonstrating innovation in translational biomedical research (Jhade, Kalidoss, Shrivastava et al., 2025)^[4^].

5. Leadership in Multidisciplinary and International Collaborative Research

Dr. Shrivastava exemplifies innovation leadership by steering diverse, multidisciplinary research projects funded by premier agencies like UGC, CSIR, and international collaborators such as King Abdul Aziz University. His work spans biotechnology, nanotechnology, bioinformatics, and molecular biology, yielding impactful outcomes in public health and environmental sustainability. Beyond his research, he has mentored numerous scholars and fostered global academic exchange, positioning himself as a catalyst for innovation and scientific excellence on an international scale

Maria Bashir, Medicine, Innovative Researcher Award

Dr. Maria Bashir: Senior Resident at Government Medical College Srinagar, India

Dr. Maria Bashir is a dedicated and accomplished medical professional specializing in Physiology, with a passion for advancing medical research and education. After completing her MBBS from Holy Family Red Crescent Medical College in Dhaka, Bangladesh, she pursued an MD in Physiology from Government Medical College Srinagar, where she deepened her understanding of human physiology and its application in clinical medicine. Currently serving as a Senior Resident in the Department of Physiology at GMC Srinagar, Dr. Bashir is committed to both her clinical duties and her research work. She has presented her research on topics such as metabolic syndrome, oxidative stress, and gastrointestinal diseases at prestigious national and international conferences. With a deep interest in integrating medical research into clinical practice, Dr. Bashir continues to contribute to the scientific community with her findings aimed at improving patient care and disease management.

Online Profiles

ORCID Profile

Education

Dr. Maria Bashir’s educational journey has been a blend of rigorous clinical training and intensive research-focused study. She completed her MBBS at Holy Family Red Crescent Medical College in Dhaka, Bangladesh, between 2008 and 2013. This program provided her with a solid foundation in general medicine, after which she further specialized in Physiology by pursuing her MD at Government Medical College Srinagar from 2020 to 2023. In addition to her medical degrees, Dr. Bashir has earned a Basic Course in Biomedical Research (BCBR) certification in March 2022, which equipped her with essential skills in research methodology and data analysis. Her educational path has enabled her to blend clinical knowledge with academic rigor, ensuring that her approach to healthcare and research is both practical and evidence-based.

Research Focus

Dr. Bashir’s research interests lie at the intersection of clinical physiology, molecular biology, and medical toxicology. Her primary focus includes studying the genetic factors influencing common dermatological conditions like acne vulgaris, as well as investigating the role of pro-inflammatory cytokines and oxidative stress in disease progression. She has also conducted extensive research on the prevalence of metabolic syndrome, particularly among medical students in the Kashmir Valley, shedding light on lifestyle and genetic factors affecting health. Dr. Bashir is deeply interested in how environmental toxins, such as organophosphorus compounds, affect human health, particularly in relation to oxidative stress. Additionally, her work on the correlation between serum vitamin D3 levels and gastrointestinal disorders, such as irritable bowel syndrome, aims to address emerging health concerns in the population. Overall, her research is driven by a desire to understand the underlying mechanisms of diseases to improve diagnostics and therapeutic strategies.

Experience

Dr. Bashir’s professional experience spans across several prestigious institutions, where she has acquired diverse clinical and academic expertise. She began her career as a Junior Resident in the Department of Gynecology and Obstetrics at SKIMS Medical College, Bemina, Srinagar in 2016, where she gained valuable hands-on experience in women’s health. Later, she transitioned to the Department of Radiodiagnosis at the same institution, broadening her exposure to medical imaging techniques. In 2019, she served as a Demonstrator in the Department of Forensic Medicine at SKIMS Medical College, where she taught undergraduate students and contributed to forensic research. After completing her MD in Physiology, Dr. Bashir continued her clinical training as a Senior Resident in the Department of Physiology at GMC Srinagar, where she currently contributes to both the academic curriculum and ongoing research. Throughout her career, Dr. Bashir has balanced clinical duties with a focus on research, actively participating in and leading studies that explore various medical conditions and treatments.

Research Timeline & Activities

Dr. Bashir’s research activities span across multiple years and have consistently contributed to the scientific community. Her research journey began during her undergraduate medical education and continued through her MD program. In 2021, she conducted a cross-sectional study on the prevalence of metabolic syndrome among first-year medical students in Kashmir, which was later presented at the 7th Annual National Conference of Association of Physiologists of India (ASSOPICON-2021). The study highlighted the role of lifestyle and genetics in the early onset of metabolic syndrome in this population. She further expanded her research into toxicology, focusing on the relationship between oxidative stress and the severity of acute organophosphorus poisoning. Dr. Bashir’s research on vitamin D3 levels in patients with irritable bowel syndrome was published in 2021 and explored the complex relationship between micronutrient deficiencies and gastrointestinal disorders. In 2023, she participated in the Uro-Surg Urology and Surgery Twin Conference in New Delhi, presenting her findings on Noonan Syndrome and the multidisciplinary approach required for its management. Dr. Bashir is actively involved in several ongoing research projects, ranging from genetic predisposition studies to large-scale clinical trials assessing the impact of various treatments on chronic health conditions.

Awards & Honors

Dr. Maria Bashir has received numerous accolades for her contributions to medical research and education. Among her most notable achievements is the Best Oral Presentation Award at the PREPARE 2021 conference, organized by Sri Ramachandra Institute of Higher Education and Research in Chennai, where her research on vitamin D3 levels in patients with irritable bowel syndrome garnered widespread recognition. Her ability to present complex scientific concepts in an accessible and engaging manner has been lauded by peers and mentors alike. In addition to the oral presentation award, Dr. Bashir’s research has been acknowledged in various academic and clinical circles, earning her the respect of her colleagues and a solid reputation in the field of Physiology and medical education.

Top Noted Publication

Dr. Bashir’s MD thesis titled “Evaluation of Genetic Predisposition, Levels of Pro-inflammatory Cytokines, and Sebum Excretion Rate in Acne Vulgaris Patients of Kashmiri Origin” stands as one of her most significant contributions to medical research. This study, which explored genetic and environmental factors influencing acne development in a specific demographic, was published in a peer-reviewed journal and has been cited in numerous studies. Another top publication is “Buzz Session as an Active Learning Method in Medical Undergraduate Physiology Teaching” (2023), co-authored with colleagues, which examined the effectiveness of active learning techniques in enhancing student engagement and learning outcomes in Physiology. Her research on the correlation between oxidative stress and organophosphorus poisoning has also been influential in the field of toxicology, contributing to a better understanding of the pathophysiological mechanisms behind acute poisoning cases. Dr. Bashir’s publications reflect her dedication to expanding knowledge in medical research, particularly in areas related to disease mechanisms, toxicology, and medical education.

Publication Overview
  • Title: Buzz Session as an Active Learning Method in Medical Undergraduate Physiology Teaching—An Institutional-Based Study

  • Journal: Medical Science Educator

  • DOI: 10.1007/s40670-023-01882-0

  • Contributors:

    • Suhail Ahmad Gilkar (Author)

    • Iram Jaan (Author)

    • Shayees Arawa (Author)

    • Mah para Nyiem (Author)

    • Maria Bashir (Author)

  • Published: September 6, 2023

  • Research Focus: This study explored the effectiveness of Buzz Sessions, an active learning technique, in enhancing undergraduate medical students’ engagement and learning outcomes in Physiology teaching. The research was conducted at an institutional level, offering insights into how active learning can be integrated into medical education.

Significance:

The paper highlights the importance of interactive and student-centered teaching methodologies, like Buzz Sessions, which encourage peer-to-peer learning and foster critical thinking. The findings could contribute to modernizing the way Physiology and other medical subjects are taught in undergraduate courses, making learning more dynamic and student-oriented.

Strength for the Innovative Researcher Award:

1. Integration of Active Learning in Medical Education

Dr. Bashir’s pioneering work in integrating Buzz Sessions as an active learning method in medical undergraduate Physiology teaching has garnered significant attention. This innovative approach fosters a more interactive, student-centered learning environment, moving away from traditional, passive lecture formats. Her research shows that such active learning techniques increase student engagement, improve critical thinking, and enhance the overall understanding of complex physiological concepts. By presenting this method in her publication, Dr. Bashir has provided a valuable model for educators to incorporate into their teaching practices. This aligns with her passion for transforming medical education to better meet the needs of future healthcare professionals.

2. Focus on Translational Research in Physiology

Dr. Bashir’s research demonstrates her commitment to translating basic scientific knowledge into clinical applications. Her MD thesis on the genetic predisposition, pro-inflammatory cytokine levels, and sebum excretion in acne vulgaris patients of Kashmiri origin is a prime example of how she links molecular and clinical research. By focusing on genetic factors and cytokine activity, she has provided insights into how these factors may influence dermatological conditions, which could eventually lead to better diagnostic and therapeutic strategies for acne vulgaris. This approach bridges the gap between basic science and clinical medicine, reflecting her ability to conduct impactful, patient-centered research.

3. Innovative Studies on Toxicology and Disease Mechanisms

Dr. Bashir’s research on the correlation between oxidative stress and acute organophosphorus poisoning stands out as an innovative exploration in medical toxicology. Through her work, she has identified the underlying pathophysiological mechanisms of organophosphorus poisoning, particularly the role oxidative stress plays in disease severity. This research not only provides deeper insights into poisoning mechanisms but also has the potential to guide clinical interventions and improve patient outcomes in poisoning cases. Dr. Bashir’s work in this area reflects her innovative approach to toxicology research, contributing to the understanding of environmental health risks.

4. Multidisciplinary Research Approach

Dr. Bashir’s interest in a multidisciplinary research approach is evident in her participation in the Uro-Surg Urology and Surgery Twin Conference, where she presented on Noonan Syndrome and the importance of a multidisciplinary management approach. This type of research, which combines knowledge from genetics, endocrinology, cardiology, and surgery, showcases her ability to address complex health issues through a collaborative and integrative perspective. Her work emphasizes the importance of treating patients from a holistic perspective, which could significantly improve patient care in various clinical settings.

5. Promoting Student Wellness through Metabolic Research

Dr. Bashir’s research into the prevalence of metabolic syndrome among first-year medical students in Kashmir exemplifies her forward-thinking approach to public health. Her findings, which suggest that lifestyle and genetic factors significantly contribute to metabolic syndrome, aim to improve early health education and lifestyle interventions for young adults. By targeting medical students, Dr. Bashir has emphasized the importance of health promotion within the medical community itself, making her research not just relevant for public health at large but also for medical practitioners who will go on to shape healthcare practices. This research highlights her proactive approach to tackling emerging health issues before they escalate.

Cemile Çelebi, Medicine, Best Innovator Award

Asst. Prof Cemile Çelebi: Assisstant Professor at Mugla Sitki Kocman University, Turkey

Dr. Cemile Çelebi is an Assistant Professor in the Department of Surgical Nursing at Muğla Sıtkı Koçman University, Faculty of Health Sciences, where she also holds the position of Vice Dean. She specializes in perioperative nursing, focusing on infection prevention, patient safety, and quality of care for surgical patients. Over the course of her career, she has combined her clinical expertise with academic research, leading projects that explore innovative approaches to surgical site infection control, pain management, and evidence-based nursing practices. Dr. Çelebi has been recognized nationally and internationally for her work, receiving awards for her scientific contributions and oral presentations, and she continues to advance the field of surgical nursing through publications, mentorship, and active participation in professional associations.

Online Profiles

ORCID Profile

Education

Dr. Çelebi’s academic journey reflects a strong foundation in both nursing practice and advanced clinical research. She earned her PhD in Surgical Nursing from Istanbul University–Cerrahpaşa in 2023, completing a dissertation that investigated the effect of active warming on the prevention of surgical site infections in abdominal surgery patients, under the supervision of Prof. Dr. İkbal Çavdar. Prior to her doctoral studies, she completed her MSc in Surgical Nursing at Istanbul University in 2015 with a thesis focusing on the information needs of day-surgery patients during the discharge process. She received her BSc in Nursing from Süleyman Demirel University in 2009, which provided her initial training as a professional nurse. Additionally, she broadened her expertise with an Associate Degree in Justice from Anadolu University in 2022, reflecting her interest in the intersections of healthcare and justice.

Research Focus

Her research primarily addresses critical aspects of perioperative nursing care, with a focus on improving patient outcomes before, during, and after surgery. She investigates methods to prevent surgical site infections, including the application of active warming techniques, and explores non-pharmacological approaches to postoperative pain management. Another area of her research emphasizes the psychological and emotional needs of both patients and nurses in surgical and intensive care settings, with special attention to stress, anxiety, and coping mechanisms. Dr. Çelebi also contributes to the growing body of evidence on communication strategies for patients under mechanical ventilation and supports the integration of evidence-based practices into nursing education and clinical practice. Her research is designed to bridge theory and practice, ensuring that nursing interventions are both scientifically validated and clinically applicable.

Experience

With over a decade of professional experience in nursing and nursing education, Dr. Çelebi has built a career that combines academic leadership, clinical research, and student mentorship. She began as a Research Assistant at Muğla Sıtkı Koçman University in 2017, where she was actively involved in both teaching and research activities in the field of surgical nursing. In 2025, she was appointed as an Assistant Professor, marking a new phase in her academic career. Her administrative leadership is reflected in her role as Vice Dean of the Faculty of Health Sciences, where she contributes to curriculum development, quality assurance, and institutional advancement. She has supervised several student research projects, particularly those funded by TÜBİTAK, and continues to integrate research findings into her teaching. Her work extends beyond the classroom to conference presentations, peer-reviewed publications, and professional organization membership, making her a well-rounded scholar-practitioner.

Research Timeline & Activities

Since 2017, Dr. Çelebi has been actively engaged in research, with a growing portfolio of projects and publications that address pressing challenges in surgical nursing. Between 2023 and 2024, she served as advisor and researcher in TÜBİTAK-supported projects investigating the use of non-pharmacological methods in pain management by intern nurses, as well as the relationship between emotional intelligence and perceived stress among nursing students. Her doctoral research provided evidence on the effectiveness of active warming in maintaining normothermia and reducing infection risk, contributing significantly to perioperative practice. She has presented her work at numerous national and international conferences, including the European Operating Room Nurses Association Congress, and has shared her expertise through invited talks, oral presentations, and posters. Her research activities demonstrate a consistent commitment to translating evidence-based findings into practical improvements for nursing education and clinical care.

Awards & Honors

Dr. Çelebi’s contributions to nursing research and education have been recognized through several prestigious awards. In 2023, she received the Research Award from the Turkish Surgical and Operating Room Nurses Association for her randomized controlled trial on preoperative oral carbohydrate intake, which was praised for its methodological rigor and clinical significance. Earlier, in 2022, she earned the Second Prize Oral Presentation Award for her study examining neurosurgical nurses’ knowledge of delirium, a condition with high relevance to postoperative care. These awards underscore her ability to conduct impactful research that addresses both clinical practice and patient outcomes. In addition to formal awards, her professional recognition includes active memberships in the Nursing Education Association (HEMED) and the Turkish Surgical and Operating Room Nurses Association, through which she contributes to the advancement of nursing science and practice.

Top Noted Publication

Among her many publications, one of Dr. Çelebi’s most influential works is her 2025 article in BMC Surgery, titled The effect of preoperative oral carbohydrate administration on postoperative glucometabolic response, subjective well-being and quality of life in patients undergoing colorectal surgery: a randomized controlled double-blind study. This study provided important insights into the benefits of nutritional interventions prior to surgery, demonstrating improvements in patient well-being, metabolic balance, and overall recovery. The publication has drawn significant academic and clinical attention, reflecting both the quality of her research design and its practical implications for perioperative care protocols.

  • Urkan, M., Çelebi, C., Meral, U. M., & Çavdar, İ. (2025). The effect of preoperative oral carbohydrate administration on postoperative glucometabolic response, subjective well-being and quality of life in patients undergoing colorectal surgery: a randomized controlled double-blind study. BMC Surgery. https://doi.org/10.1186/s12893-025-03093-3

  • Çelebi, C., Güngör, F. B., Sivrikaya, İ., & Çavdar, İ. (2024). Lived Experiences, Emotional and Psychological Needs of Covid-19 Emergency Service Nurses: A Qualitative Study. Black Sea Journal of Health Science. https://doi.org/10.19127/bshealthscience.1413718

  • Çelebi, C., & Kanan, N. (2023). Günübirlik Cerrahi Hastalarının Taburculuk Aşamasındaki Bilgi Gereksinimlerinin Belirlenmesi. Black Sea Journal of Health Science. https://doi.org/10.19127/bshealthscience.1220826

  • Balci, F., Seyhan Ak, E., Çelebi, C., İğci Şanlı, S., & Özbaş, A. (2023). Determining the Risk of Intraoperative Pressure Injury in Patients Undergoing Elective Cranial Surgery. Journal of Basic and Clinical Health Sciences. https://doi.org/10.30621/jbachs.1063029

  • Çelebi, C., Balkan, A., & Saruhan, E. (2022). Cerrahi Hemşirelerinin Cerrahi Alan İnfeksiyonlarını Önlemeye Yönelik Bilgi Düzeyleri. Sağlık Akademisi Kastamonu. https://doi.org/10.25279/sak.828562

Raksha Mhetre, Medicine, Female Researcher Award

Dr: Raksha Mhetre: Associate Professor at PES Modern College of Pharmacy (for Ladies), India

  • Title/Designation: Dr.

  • Name: Raksha Mhetre

  • Current Role/Designation: Associate Professor

  • Organization/Institution Details: PES Modern College of Pharmacy (for Ladies)

  • Country: India

  • Subject Track: Medicine

  • Award Categories: Female Researcher Award

  • Submitted: August 21, 2025

Dr. Raksha Laxman Mhetre is a dedicated pharmaceutical scientist and academician with over 15 years of teaching and research experience in the field of pharmaceutics. Currently serving as Associate Professor and College Examination Officer at Modern College of Pharmacy (For Ladies), Pune, she is known for her expertise in nanotechnology, novel drug delivery systems, and pharmaceutical formulation. Her work bridges the gap between innovative academic research and practical pharmaceutical application. She has mentored numerous postgraduate students, received significant research funding, authored impactful publications, and actively contributes to curriculum development for pharmacy education under Savitribai Phule Pune University.

Online Profiles

ORCID Profile

Education

Dr. Mhetre earned her Ph.D. in Pharmaceutics from Modern College of Pharmacy for Ladies, Pune, affiliated with Savitribai Phule Pune University, in 2020. She completed her M.Pharm in Pharmaceutics from C. U. Shah College of Pharmacy, Mumbai, under SNDT Women’s University in 2009, achieving first class. She holds a B.Pharm degree with distinction from Dr. D. Y. Patil Institute of Pharmaceutical Sciences, Pune. She qualified national-level competitive exams like GATE with 98.3 percentile and secured an All India Rank of 205 in NIPER-JEE, demonstrating her academic excellence early in her career.

Research Focus

Her primary research interests lie in the design and development of advanced drug delivery systems with a special focus on nanotechnology, nanosuspensions, co-crystals, and sustained release formulations. She is deeply involved in improving the solubility, stability, and bioavailability of poorly water-soluble drugs using techniques such as crystal engineering, nanosizing, and lipid-based drug delivery systems. Dr. Mhetre also explores the integration of herbal therapeutics in pharmaceutical dosage forms, merging traditional knowledge with modern delivery technologies.

Experience

Dr. Mhetre began her academic journey as an Assistant Professor at RJSPM’s College of Pharmacy, Alandi, Pune, where she worked from 2009 to 2019. Since August 2019, she has been working with Modern College of Pharmacy (For Ladies), Pune, where she now holds the position of Associate Professor. In addition to teaching core subjects like Pharmaceutics and Modern Dispensing Practices, she serves as the College Examination Officer and PG research guide. She also has valuable industry exposure from working in the Tech-Transfer department of Themis Medicare, Haridwar, enriching her academic teaching with real-world pharmaceutical insight.

Research Timeline & Activities

Over her academic career, Dr. Mhetre has led and participated in multiple research initiatives, including a BCUD-funded major research project worth ₹2.5 lakhs. Her doctoral research focused on nanoparticulate drug delivery, while her postgraduate work revolved around sustained release technologies. She has guided eight postgraduate dissertations, filed four patents, co-authored a textbook on Novel Drug Delivery Systems, and contributed a book chapter published by De Gruyter. She has actively presented at over 50 national and international conferences and plays a vital role in curriculum and syllabus development under SPPU.

Awards & Honors

Dr. Raksha Mhetre has received numerous awards and honors in recognition of her academic and research excellence. She was awarded the prestigious Lila Poonawalla Fellowship in 2007 for securing the highest marks in B.Pharm. She also received the Sir Ratan Tata Scholarship and Bajaj Scholarship during her undergraduate studies. She was a university topper during her B.Pharm course and won second prize for oral presentation at the Indian Pharmaceutical Association Conference in 2009. Her dedication to academic excellence continues to earn her accolades within the academic and research community.

Top Noted Publication

Among her body of work, one of the most cited and appreciated publications is “Optimisation of Cilnidipine Nanoparticles using Box-Behnken Design: in vitro, toxicity, and biavailability assessment” published in Materials Technology (2021). This research demonstrates a successful application of statistical design of experiments in the formulation of antihypertensive nanoparticles, enhancing drug solubility and bioavailability. The study has been referenced in subsequent work on nanopharmaceuticals and has contributed to advancements in targeted and controlled drug delivery technologies.

  • Patent Review on Colon-Targeted Drug Delivery System
    Bulletin for Technology and History Journal, 2023
    Contributor: Dr. Raksha Mhetre
    A comprehensive review discussing recent patent trends, innovations, and formulation strategies in colon-specific drug delivery systems.

  • Recent Advancement in Colon-Targeted Drug Delivery
    International Journal of Creative Research Thoughts, 2023
    Contributor: Dr. Raksha Mhetre
    Focuses on modern approaches to colon-targeted drug delivery, highlighting carrier systems, mechanisms of targeting, and clinical applications.

  • Textbook of Novel Drug Delivery System
    Book, 2023
    Author: Dr. Raksha Mhetre
    An academic textbook covering fundamental and advanced concepts in novel drug delivery technologies, including nanocarriers, targeted delivery, and formulation strategies. ISBN: 978-93-92159-86-2

  • A Review on Fast-Dissolving Oral Film
    Asian Journal of Pharmaceutical and Clinical Research, Vol. 16(10), 2023
    DOI: 10.22159/ajpcr.2023.v16i10.48099
    Contributors: Komal A. Kawale, Neha B. Autade, Harshada S. Narhare, Dr. Raksha L. Mhetre
    A detailed analysis of formulation techniques, evaluation parameters, and applications of fast-dissolving oral films in drug delivery.

  • Nanonization-Based Solubility Enhancement by Loaded Porous Starch Foam: Nifedipine Tablet Formulation
    Journal of Pharmaceutical Innovation, March 2023
    DOI: 10.1007/s12247-022-09622-4
    Contributors: Pratibha M. Chaudhari, Paul Johnson, Dr. Raksha L. Mhetre, Antoine Al-Achi
    This research presents a novel approach for solubility enhancement of nifedipine using porous starch foam carriers, supporting improved bioavailability in oral tablets.

Strengths for the Female Researcher Award
  1. Pioneering Contributions to Nanotechnology & Drug Delivery
    Dr. Mhetre has significantly advanced the field of pharmaceutics through her innovative research in nanoparticulate systems, co-crystals, and solubility enhancement techniques. Her work on cilnidipine nanoparticles and starch-based delivery systems has practical implications in improving drug bioavailability, making her a trailblazer in targeted and sustained-release formulations.

  2. Leadership in Academic Research and Mentorship
    With over 15 years of academic service, she has successfully mentored postgraduate students and guided them through advanced research methodologies. Her role as a postgraduate research guide and her involvement in curriculum development at Savitribai Phule Pune University demonstrate her strong commitment to shaping future scientists and educators.

  3. Patent Holder and Published Author
    Dr. Mhetre has authored four pharmaceutical patents, contributed to impactful scientific journals, and co-authored a textbook on Novel Drug Delivery Systems. These contributions reflect both her technical expertise and her ability to translate complex research into applied pharmaceutical innovations.

  4. Role Model in Women’s STEM Education
    Serving at an all-women’s pharmacy college, she not only leads by example in a male-dominated field but also actively empowers female students through mentorship, academic leadership, and engagement in women-centric educational foundations such as the Lila Poonawalla Foundation.

  5. Recognized Academic Excellence and Public Engagement
    Awarded prestigious fellowships and scholarships like the Lila Poonawalla Fellowship, Sir Ratan Tata Scholarship, and the Bajaj Scholarship, Dr. Mhetre’s excellence is widely acknowledged. Her consistent participation in over 50 national and international conferences and editorial roles further highlights her commitment to scientific outreach and public engagement.

Manish Bhartiya, Medicine, Best Researcher Award

Prof. Manish Bhartiya: Professor Medicine and Neurology at CHSC, India

Title/Designation: Prof.

Name: Manish Bhartiya

Current Role/Designation: Professor of Medicine and Neurology

Organization/Institution Details: Command Hospital, Pune (CHSC)

Country: India

Subject Track: Medicine

Key Areas of Expertise: Neurology

Award Categories: Best Researcher Award

Submitted: Aug 18, 2025

Manish Bhartiya is a highly respected neurologist, serving at the Base Hospital in Guwahati. With an academic background that includes a DM in Neurology from AIIMS, New Delhi, and an MBBS & MD in General Medicine from AFMC, Pune, Dr. Bhartiya has established himself as an expert in the field of neurology and stroke management. In addition to his clinical expertise, he has contributed significantly to the medical community through his role in academic teaching, research, and editorial work. He played a pivotal role in setting up comprehensive neurological services at Base Hospital, which includes an accredited acute stroke unit, aimed at enhancing the quality of care for patients.

Online Profiles

Scopus Profile

Research Impact:
  • Citations: 142

  • Documents: 16

  • h-index: 5 (The h-index reflects both the productivity and citation impact of the author’s work. An h-index of 5 means that Dr. Bhartiya has at least 5 publications with 5 or more citations each.)

Dr. Bhartiya’s work is highly regarded in the academic and clinical research community, with his publications contributing to advancements in neurology, stroke management, and neurocritical care. His work is widely cited by researchers and clinicians alike, reflecting his influence and the importance of his contributions to the field. The h-index of 5 suggests a solid impact on the research community, with his work being cited by others in notable medical and academic journals.

Education

Dr. Bhartiya’s foundational education includes an MBBS & MD in General Medicine from AFMC, Pune, where he was recognized with a Gold Medal for excellence in his MD program. He later pursued specialized training in Neurology, earning a DM in Neurology from AIIMS, New Delhi, one of the leading institutions for medical education in India. His strong academic foundation not only supports his clinical practice but also shapes his ability to contribute to medical literature and guide younger generations of healthcare professionals.

Research Focus

Dr. Bhartiya’s primary research interests lie in neurological diseases, especially acute stroke management, neurodegenerative disorders, and epilepsy. He focuses on early diagnosis, advanced therapeutic interventions, and rehabilitation techniques to improve the outcomes for patients with neurological disorders. His research includes cutting-edge work on stroke pathophysiology, neuroprotective agents, and post-stroke rehabilitation. Additionally, he explores medical emergency management and is keen on developing protocols that can be implemented at the grassroots level to enhance patient care across diverse settings.

Experience

Dr. Bhartiya has a wealth of clinical experience, having worked in multiple prestigious institutions, including his role as a Faculty Member in the Dept. of Medicine at AFMC, Pune, from 2013 to 2015. During his tenure, he was instrumental in developing the department’s medical curriculum and training future medical professionals. As a neurologist at the Base Hospital, Guwahati, he has not only delivered patient care but also spearheaded initiatives such as the Comprehensive Neurological Services and Accredited Acute Stroke Unit. These innovations have been central to improving the neurological care infrastructure in the region. His leadership and ability to integrate clinical care with cutting-edge medical research set him apart in the field.

Research Timeline & Activities

Dr. Bhartiya’s research trajectory began during his academic years, continuing through his work as a faculty member and clinician. His research timeline spans over 15 years, with significant contributions to stroke management, epilepsy, and neurodegenerative diseases. In addition to publishing articles in high-impact medical journals, he has presented research papers at major national and international conferences such as APICON, IANCON, and IJMPHE. These conferences have allowed him to share his findings on neurocritical care, stroke treatment protocols, and advancements in neurological rehabilitation. His active involvement in research ensures that his clinical practices remain at the forefront of neurological care.

Awards & Honors

Dr. Bhartiya’s career has been marked by several prestigious awards, including a Gold Medal for his MD in General Medicine from AFMC, Pune. His contributions to the field of neurology and stroke care have earned him widespread recognition in academic and medical circles. His clinical expertise, paired with his commitment to medical education and research, has led to multiple awards for excellence in patient care and teaching. He continues to be an influential figure in both the academic and clinical aspects of neurology, with a reputation for both excellence and innovation.

Top Noted Publication

One of Dr. Bhartiya’s top publications is his seminal work on acute stroke management in a renowned international journal. This publication, which explores emergency stroke protocols, neuroprotective strategies, and early intervention techniques, has been widely cited by fellow neurologists and healthcare professionals. It has served as a reference point for clinicians involved in acute stroke care. Dr. Bhartiya’s ability to combine clinical insights with cutting-edge research allows his publications to serve as practical resources for medical professionals. Additionally, his contributions to medical textbooks, such as Handbook of ECGs for Undergraduates, further extend his influence in medical education.

  • Title: Clinical Profile of High-Altitude Cerebral Edema: A Case Series

  • Journal: Annals of Indian Academy of Neurology

  • Year: 2025

  • Access: Open Access

This research focuses on High-Altitude Cerebral Edema (HACE), a severe and potentially life-threatening condition associated with high altitudes, and provides insights into its clinical profile based on a case series. It’s likely an important contribution to the understanding of neurological complications related to high-altitude exposure.

Strength for the Best Researcher Award 
  1. Advancements in Acute Stroke Management
    Prof. Bhartiya has pioneered early diagnosis and rapid intervention protocols for stroke care, particularly in acute settings. His research focuses on neuroprotective strategies and timely therapeutic interventions, contributing to better survival rates and functional recovery for stroke patients.

  2. Establishment of the Accredited Acute Stroke Unit
    His role in establishing an accredited Acute Stroke Unit at Base Hospital, Guwahati has been groundbreaking. This unit implements state-of-the-art stroke management techniques, improving patient outcomes by providing 24/7 expert care and accelerating diagnosis and treatment for stroke patients in a timely manner.

  3. Neurodegenerative Diseases Research and Early Diagnosis
    Prof. Bhartiya’s research into neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s) focuses on early diagnosis, therapeutic interventions, and rehabilitation strategies. His work is instrumental in creating diagnostic protocols and improving the quality of life for patients with long-term neurological conditions.

  4. High-Altitude Cerebral Edema (HACE) Research
    His work on High-Altitude Cerebral Edema (HACE) has provided a comprehensive clinical profile of the condition, contributing valuable knowledge to the management of this high-altitude neurological emergency. This research has been a vital resource for clinicians in remote and high-altitude regions.

  5. Neurocritical Care & Post-Stroke Rehabilitation
    Prof. Bhartiya’s research in neurocritical care, especially regarding post-stroke rehabilitation, has influenced clinical practices globally. His work on neuroprotective agents and rehabilitation techniques offers valuable insights into improving long-term recovery for patients with acute neurological injuries, particularly in stroke survivors.

Archana Gaur, Medicine, Female Researcher Award

Dr. Archana Gaur: Associate Professor at All India Institute of Medical Sciences Bibinagar, India

Dr. Archana Gaur T is an Associate Professor in the Department of Physiology at AIIMS Bibinagar, Hyderabad. With a comprehensive background in both clinical and academic spheres, Dr. Gaur has over 12 years of experience in teaching, research, and healthcare. She obtained her MBBS from Kilpauk Medical College, Chennai, and her MD in Physiology from JIPMER, Puducherry. She also holds a Fellowship Certificate in Diabetology & Noncommunicable Diseases. Her work spans diverse areas of Physiology, with a particular focus on metabolic disorders, neuroendocrinology, and clinical physiology, especially the pathophysiology of diabetes, obesity, and neuropathies. Dr. Gaur has contributed significantly to the understanding of the physiological mechanisms underlying these conditions, and her research continues to have a profound impact on the medical community.

Online Profiles

Scopus Profile

Dr. Gaur is an active member of several professional bodies such as the Indian Medical Association (IMA), the Association of Physiologists of India (APPI), the Indian Society for Sleep Research (ISSR), and the Research Society for the Study of Diabetes in India (RSSDI). She is an editorial board member of several well-regarded journals, including the European Journal of Clinical and Biomedical Sciences and the World Journal of Public Health. Her expertise is frequently sought by academic and research institutions, where she contributes as a peer reviewer for many peer-reviewed journals, such as IJPP, AJRRE, and Frontiers in Public Health. Dr. Gaur is also involved in various initiatives related to teaching, research, and public health, strengthening the knowledge base in her areas of expertise.

Research Impact

  • Citations: 88 citations from 87 documents

  • h-index: 6

Education

  • MBBS: Kilpauk Medical College, Chennai (2007)
    This foundational degree in medicine gave Dr. Gaur a solid understanding of human biology and healthcare systems.

  • MD Physiology: JIPMER, Puducherry (2011)
    Specializing in Physiology, Dr. Gaur advanced her clinical knowledge and research skills, contributing to the field of medical sciences.

  • Fellowship Certificate Course in Diabetology & Noncommunicable Diseases: IMA College of General Practitioners, Chennai (2017)
    Focused on diabetes management and the prevention of noncommunicable diseases, this fellowship enhanced her clinical expertise.

  • Certified Polysomnographic Technologist
    Dr. Gaur became a certified expert in sleep study techniques, furthering her knowledge in sleep disorders and their impact on metabolic health.

Research Focus

Dr. Gaur’s research is focused on understanding the physiological basis of various noncommunicable diseases, particularly diabetes, obesity, and neuroendocrine disorders. She is deeply involved in the study of small fiber neuropathy and sleep disturbances, exploring their associations with chronic diseases like diabetes and alcohol dependence. Her research includes studying the role of diet and exercise in managing adolescent obesity and investigating the neurotrophic factors that influence the progression of diabetic neuropathy. Dr. Gaur’s work is significant not only in academic circles but also in improving clinical outcomes for patients with metabolic diseases.

Experience

With more than a decade of academic experience, Dr. Gaur has made notable contributions to both education and research. She has taught a wide array of undergraduate and postgraduate students, enriching their understanding of human physiology and clinical practices. Over the years, she has been an investigator for a number of research projects funded by both national and international agencies. Her leadership in projects has led to advancements in understanding the physiological mechanisms of diabetes, sleep disorders, and the implications of diet on metabolic health. As a Principal Investigator (PI) and Co-Principal Investigator (Co-PI) on multiple studies, Dr. Gaur has contributed to clinical trials and observational studies that have furthered research in the field of Physiology.

Research Timeline & Activities

Dr. Gaur’s research activities span over a decade, with her involvement in several funded and non-funded projects. Notable ongoing studies include the evaluation of neuropathy in newly diagnosed type 2 diabetes patients, investigating the effects of artificial sweeteners on liver tissue, and understanding how night shifts impact sleep patterns and mental well-being in security personnel. Past projects have included studies on the impact of diet modification and physical activity on adolescent obesity, as well as examining the role of neurotrophic factors in diabetic neuropathy. Dr. Gaur has also worked on projects exploring the relationship between alcohol dependence syndrome and peripheral neuropathy, sleep disturbances, and the cardiovascular risks in patients with psoriasis. Her research has resulted in several successful publications and valuable contributions to her field.

Awards & Honors

Dr. Gaur’s research contributions have earned her several prestigious awards. She was honored with the AV Tilak Parvathi Devi Award in 2022 for the Best Research Paper in Neuro-Endocrinology. In 2023, she received the Novartis RSSDI Young Investigator Award, recognizing her innovative work in the field of diabetes and endocrinology. Recently, she was awarded the ASIM DAS APPI Award in 2024 for her outstanding contributions to clinical physiology. These accolades underscore Dr. Gaur’s exceptional contributions to medical science and her commitment to advancing the understanding of metabolic diseases.

Top Noted Publication

Dr. Gaur has authored more than 80 publications in high-impact journals, and her work has contributed significantly to advancing medical knowledge. A standout contribution is the “Spirometry” chapter in the book Practical Physiology by Dr. Prasunpriya Nayak, published in 2021. Another notable publication is “Physiology Essentials Navigating Charts, OSPE, OSCE, and Calculations Part 1” (2023), co-authored with Senthil Kumar and Rajathi Rajendran, which offers invaluable insights into clinical physiology education. These works have been well-received by medical students and practitioners alike. Dr. Gaur’s research on topics such as neuroendocrine physiology, diabetes, and sleep disorders has been published in numerous high-impact journals, further solidifying her reputation in the academic community.

  • “High-fat Diet Coupled with Aerobic Exercise Has a Sexually Dimorphic Effect on the Biochemical Profile and Anxiety-like Behaviour of Adolescent Wistar Rats”
    Published in Annals of Neurosciences (2025)
    This open-access article explores how a high-fat diet, combined with aerobic exercise, differentially affects the biochemical profile and anxiety-like behavior in male and female adolescent Wistar rats. The findings provide insight into sex-specific responses to dietary and exercise interventions in metabolic health and psychological well-being.

  • “Neutrophil Gelatinase-associated Lipocalin, Kidney Injury Molecule-1, and Periostin: Novel Urinary Biomarkers in Diabetic Nephropathy”
    Published in World Journal of Nephrology (2024)
    This study highlights the potential of novel urinary biomarkers—neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and periostin—in diagnosing and monitoring diabetic nephropathy. The work contributes to the understanding of early biomarkers in diabetic kidney disease, potentially offering new avenues for early detection and intervention.
    Citations: 2

Yang Zhou, Medicine, Best Innovator Award

Dr. Yang Zhou: Physician at The Second Affiliated Hospital of Nanjing Medical University, China

Dr. Yang Zhou, MD, PhD, is an Associate Professor of Medicine and Associate Chief Physician of Nephrology at the Center for Kidney Disease, the Second Affiliated Hospital of Nanjing Medical University (NJMU). With extensive experience in clinical nephrology and translational research, she is a leading expert in diabetic kidney disease. Her dual role in academia and hospital practice enables her to integrate scientific research with patient care, contributing meaningfully to the advancement of nephrology in China.

Online Profiles

ORCID Profile

Education

Dr. Zhou completed her MD and PhD degrees in Nephrology at Nanjing Medical University in 2014, following a rigorous residency program she completed in 2012. Her doctoral training combined intensive clinical exposure with laboratory research, which prepared her for a career bridging both domains. This strong academic foundation has informed her approach to clinical decision-making, evidence-based treatment, and investigative inquiry into kidney diseases.

Research Focus

Dr. Zhou’s primary research interests revolve around the mechanisms, progression, and treatment of diabetic kidney disease. Her work seeks to identify molecular pathways involved in renal fibrosis, inflammation, and metabolic dysfunction. She is also involved in developing early diagnostic markers and novel therapeutic targets. Her research is supported by the National Natural Science Foundation of China (NSFC) and the Jiangsu Provincial Science Foundation, emphasizing the clinical relevance and innovation of her work.

Experience

Since 2012, Dr. Zhou has served in a series of progressive clinical and academic roles. She began as an Attending Physician at NJMU and was promoted to Associate Professor and Associate Chief Physician in 2018. In addition to treating patients, she leads clinical trials, supervises postgraduate students, and participates in hospital leadership and policy-making. Her combined academic and medical expertise positions her as a key figure in nephrology research and education in Jiangsu Province.

Research Timeline & Activities

Dr. Zhou’s research trajectory over the past decade highlights a consistent focus on chronic kidney disease, particularly in diabetic populations. From her early investigations into renal cell signaling to recent projects on therapeutic interventions, she has maintained a productive and evolving research portfolio. She frequently presents her findings at national and international nephrology conferences and collaborates with multidisciplinary teams to translate lab findings into clinical practice.

Awards & Honors

Dr. Zhou’s excellence in medicine and research has been widely recognized. She was selected for the Jiangsu Provincial 333 High-Level Talent Cultivation Project and included in the prestigious Six Talent Peaks Program, both of which acknowledge her leadership in clinical research. She is also a recipient of the Jiangsu Provincial Youth Medical Talents Program and has received multiple Provincial Science and Technology Awards for her contributions to nephrology.

Top Recent Publication

Among her recent scholarly works, a notable publication appeared in Kidney International, where Dr. Zhou co-authored a study on the identification of novel biomarkers for early-stage diabetic nephropathy. This study, which employed both clinical cohort analysis and mechanistic exploration, offers new insights into early detection and risk stratification, potentially influencing clinical protocols for diabetic kidney disease management.

  • Clusters of Body Fat and Nutritional Parameters are Strongly Associated with Diabetic Kidney Disease in Adults with Type 2 Diabetes
    Diabetes Therapy, January 2024
    DOI: 10.1007/s13300-023-01502-5
    Explores the association between body fat distribution patterns and nutritional markers with diabetic kidney disease, providing evidence for metabolic phenotyping in DKD risk assessment.

  • Loss of UCP2 Causes Mitochondrial Fragmentation by OMA1‐Dependent Proteolytic Processing of OPA1 in Podocytes
    The FASEB Journal, November 2023
    DOI: 10.1096/fj.202301055R
    Investigates how UCP2 deficiency leads to mitochondrial dysfunction in podocytes through the OMA1–OPA1 pathway, contributing to kidney injury mechanisms.

  • Pyruvate Kinase M2 Regulates Mitochondrial Homeostasis in Cisplatin-Induced Acute Kidney Injury
    Cell Death & Disease, October 2023
    DOI: 10.1038/s41419-023-06195-z
    Highlights the role of PKM2 in maintaining mitochondrial balance during cisplatin-induced nephrotoxicity, with potential implications for AKI treatment.

  • Urinary Metabolites Associate with the Presence of Diabetic Kidney Disease in Type 2 Diabetes and Mediate the Effect of Inflammation on Kidney Complication
    Acta Diabetologica, May 2023
    DOI: 10.1007/s00592-023-02094-z
    Demonstrates how specific urinary metabolites are linked with DKD and how they mediate inflammatory pathways, suggesting potential for non-invasive biomarkers.

  • SGLT2 Inhibitor Counteracts NLRP3 Inflammasome via Tubular Metabolite Itaconate in Fibrosis Kidney
    The FASEB Journal, January 2022
    DOI: 10.1096/fj.202100909RR
    Shows how SGLT2 inhibitors exert anti-fibrotic effects in the kidney through modulation of the NLRP3 inflammasome and the anti-inflammatory metabolite itaconate.

  • Sirtuin 3 Regulates Mitochondrial Protein Acetylation and Metabolism in Tubular Epithelial Cells During Renal Fibrosis
    Cell Death & Disease, September 2021
    DOI: 10.1038/s41419-021-04134-4
    Explores how SIRT3 affects mitochondrial function and cellular metabolism during kidney fibrosis, providing a mechanistic basis for therapeutic targeting.

  • CPT1α Maintains Phenotype of Tubules via Mitochondrial Respiration During Kidney Injury and Repair
    Cell Death & Disease, August 2021
    DOI: 10.1038/s41419-021-04085-w
    Investigates the protective role of CPT1α in tubular epithelial cells, linking mitochondrial respiration to kidney repair processes.